Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease.

James E HanSun K YiSteven WangAudrey ErmanShethal BearellySimran SindhuJared R RobbinsJulie BaumanCharles C Hsu

Published in: Head & neck (2019)

NAC may improve OS among nonendemic NPC patients at higher risk of distant micrometastases, particularly N3 disease and those with unfavorable histology.

Keyphrases

neoadjuvant chemotherapy
locally advanced
rectal cancer
lymph node
squamous cell carcinoma
sentinel lymph node
radiation therapy
transcription factor
early stage